Neuro-X is a computational drug design company that builds a platform to better understand degenerative disorders of the brain. They utilize data and machine learning to identify novel drivers of disease and then design molecules for those diseases in silico. Their website, https://www.neurox1.com/, provides information about their team, which includes Co-Founder and CEO Max Dordevic, Co-Founder and CIO Conner Myers, Co-Founder and CTO Lucas Myers, Computational Chemist Nassim Beiranvand, Chemical Software Engineer Joseph Raso, Bioinformatics Scientist Dereck Mezquita, and Machine Learning Engineer Aidan Morzenti.
Location: United States, Texas, Austin
Employees: 1-10
Total raised: $500K
Founded date: 2021